Supply Glut Prompts a Look Beyond Labs

Greater Boston’s 16 million-square-foot lab construction pipeline used to represent an exclamation point for the region’s life science industry. Today, it’s one of the biggest question marks in the local commercial real estate market.

Everyone Wants a Piece of Biotech Startups

As life science tenant space requirements become scarcer in the more conservative venture capital climate, Boston area developers are adapting to the new leasing landscape with incubator space aimed at small startups.

VC Funding Rebound Favors Mass. Biotechs

Venture capital investment in Greater Boston’s life science industry rose to its highest level in more than a year, as local companies scored six of the 10 largest deals nationwide during the second quarter.

Personnel File – No. 333

Who’s on the move? From new VPs to fresh project managers, see who’s been hired, promoted and honored: It’s the latest edition of Banker & Tradesman’s Personnel File.

Recovering Fundamentals Attract Investor Demand

The Boston area’s high barriers to entry have suppressed new development and contributed to nine consecutive quarters of positive retail absorption. Given increasing tenant demand and a static supply side, the market has seen strong rental growth which we expect to continue.

New Weston Labs Get First Biotech Tenant

The speculative redevelopment of Weston’s former Liberty Mutual office park into life science space received its first tenant commitment from a Natick biotech that was acquired last year for $300 million.